Abstract:
The present disclosure relates to a method and to an apparatus, both arranged for controlling acoustic signals to be recorded or reproduced by an electro-acoustical sound system. An initial digital filter is determined by solving an inverse problem, wherein the initial digital filter is configured to control acoustic signals to be recorded and/or reproduced by the electro-acoustical sound system; a frequency-dependent articulation parameter is determined by executing a time spectral psychoacoustic automatic audio quality test on the initial digital filter; a frequency-dependent regularization parameter, used for determining the initial digital filter, is tuned by use of the frequency-dependent articulation parameter; and, by use of the tuned frequency-dependent regularization parameter, a digital filter configured to control acoustic signals to be recorded or reproduced by the electro-acoustical sound system is determined.
Abstract:
The present invention relates to a composition comprising urolithin A, urolithin B, urolithin C, urolithin D, or a combination thereof, for the stimulation of insulin secretion, and to the use of a compound chosen among urolithin A, urolithin B, urolithin C, urolithin D, or a combination thereof, intended for the stimulation of insulin secretion. The present invention also relates to a composition comprising an effective amount of urolithin B, urolithin C, urolithin D, or a combination thereof, for the treatment or the prevention of diabetes mellitus, and in particular for the treatment or the prevention of type 2 diabetes, and to the use of a compound chosen among urolithin B, urolithin C, urolithin D, and a combination thereof, intended for the treatment or the prevention of diabetes mellitus, and in particular of type 2 diabetes.
Abstract:
The present invention relates to a composition comprising urolithin A, urolithin B, urolithin C, urolithin D, or a combination thereof, for the stimulation of insulin secretion, and to the use of a compound chosen among urolithin A, urolithin B, urolithin C, urolithin D, or a combination thereof, intended for the stimulation of insulin secretion. The present invention also relates to a composition comprising an effective amount of urolithin B, urolithin C, urolithin D, or a combination thereof, for the treatment or the prevention of diabetes mellitus, and in particular for the treatment or the prevention of type 2 diabetes, and to the use of a compound chosen among urolithin B, urolithin C, urolithin D, and a combination thereof, intended for the treatment or the prevention of diabetes mellitus, and in particular of type 2 diabetes.
Abstract:
The present invention relates to a composition comprising urolithin A, urolithin B, urolithin C, urolithin D, or a combination thereof, for the stimulation of insulin secretion, and to the use of a compound chosen among urolithin A, urolithin B, urolithin C, urolithin D, or a combination thereof, intended for the stimulation of insulin secretion. The present invention also relates to a composition comprising an effective amount of urolithin B, urolithin C, urolithin D, or a combination thereof, for the treatment or the prevention of diabetes mellitus, and in particular for the treatment or the prevention of type 2 diabetes, and to the use of a compound chosen among urolithin B, urolithin C, urolithin D, and a combination thereof, intended for the treatment or the prevention of diabetes mellitus, and in particular of type 2 diabetes.
Abstract:
The disclosure relates to a microphone assembly (100) for acquiring a plurality of audio signals, wherein the microphone assembly (100) has a reconfigurable geometry so that the microphone assembly (100) may be configured to be embedded in or attached to a body. The microphone assembly (100) comprises: a plurality of digital microphones (101a-h) configured to convert the sound signal impinging on each digital microphone into a corresponding digital electrical signal, a digital signal processing unit (102) comprising a serial digital communication interface (102a) and a processor (102b), and a connecting and mounting structure configured to provide a flexible electrical connection and a flexible mechanical arrangement for the plurality of digital microphones (101a-h).
Abstract:
The present invention relates to a method and to an apparatus, both arranged for controlling acoustic signals to be recorded or reproduced by an electro-acoustical sound system. For this purpose: an initial digital filter is determined by solving an inverse problem, wherein the initial digital filter is configured to control acoustic signals to be recorded and/or reproduced by the electro-acoustical sound system; a frequency-dependent articulation parameter is determined by executing a time spectral psychoacoustic automatic audio quality test on the initial digital filter; a frequency-dependent regularization parameter, used for determining the initial digital filter, is tuned by use of the frequency-dependent articulation parameter; and, by use of the tuned frequency-dependent regularization parameter, a digital filter configured to control acoustic signals to be recorded or reproduced by the electro-acoustical sound system is determined.
Abstract:
The present invention relates to a composition comprising urolithin A, urolithin B, urolithin C, urolithin D, or a combination thereof, for the stimulation of insulin secretion, and to the use of a compound chosen among urolithin A, urolithin B, urolithin C, urolithin D, or a combination thereof, intended for the stimulation of insulin secretion. The present invention also relates to a composition comprising an effective amount of urolithin B, urolithin C, urolithin D, or a combination thereof, for the treatment or the prevention of diabetes mellitus, and in particular for the treatment or the prevention of type 2 diabetes, and to the use of a compound chosen among urolithin B, urolithin C, urolithin D, and a combination thereof, intended for the treatment or the prevention of diabetes mellitus, and in particular of type 2 diabetes.
Abstract:
The disclosure relates to a microphone assembly (100) for acquiring a plurality of audio signals, wherein the microphone assembly (100) has a reconfigurable geometry so that the microphone assembly (100) may be configured to be embedded in or attached to a body. The microphone assembly (100) comprises: a plurality of digital microphones (101a-h) configured to convert the sound signal impinging on each digital microphone into a corresponding digital electrical signal, a digital signal processing unit (102) comprising a serial digital communication interface (102a) and a processor (102b), and a connecting and mounting structure configured to provide a flexible electrical connection and a flexible mechanical arrangement for the plurality of digital microphones (101a-h).
Abstract:
The present invention relates to a composition comprising urolithin A, urolithin B, urolithin C, urolithin D, or a combination thereof, for the stimulation of insulin secretion, and to the use of a compound chosen among urolithin A, urolithin B, urolithin C, urolithin D, or a combination thereof, intended for the stimulation of insulin secretion. The present invention also relates to a composition comprising an effective amount of urolithin B, urolithin C, urolithin D, or a combination thereof, for the treatment or the prevention of diabetes mellitus, and in particular for the treatment or the prevention of type 2 diabetes, and to the use of a compound chosen among urolithin B, urolithin C, urolithin D, and a combination thereof, intended for the treatment or the prevention of diabetes mellitus, and in particular of type 2 diabetes.